Divis Laboratories (India) holds 38 active US FDA Type II Drug Master Files and 18 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Divis Laboratories: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/divis-laboratories

Overview

Divis Laboratories is a pharmaceutical company headquartered in Hyderabad, India.

Core services & business areas

Active Pharmaceutical Ingredients (API)IntermediatesNutraceutical IngredientsCustom Synthesis

Active ingredients with DMF or CEP filings

Substances for which Divis Laboratories holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Divis Laboratories holds 38 active (56 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BRIVARACETAMActive2025-03-31
  • LOSARTAN POTASSIUM USPActive2024-09-26
  • RIVAROXABAN USPActive2024-09-19
  • IRBESARTAN USPActive2023-11-07
  • TICAGRELORActive2022-01-27
  • ORLISTATActive2021-04-30
  • LACOSAMIDEActive2021-03-09
  • VIGABATRIN USPActive2017-07-29
  • PREGABALIN (ALTERNATIVE PROCESS)Active2016-08-01
  • LEVETIRACETAM (PROCESS B)Active2016-01-08
  • MESALAMINE USPActive2015-11-06
  • OLMESARTAN MEDOXOMIL USPActive2014-01-28
  • VALSARTAN USPActive2011-03-29
  • TRITYL LOSARTANActive2010-09-15
  • 2-4-WING A ESTERActive2010-07-23
  • SUMATRIPTAN SUCCINATE AND SUMATRIPTANActive2010-03-10
  • VENLAFAXINE HCLActive2009-01-28
  • DEXTROMETHORPHAN BASE USPActive2009-01-28
  • KETOENAMINEActive2008-10-05
  • QUETIAPINE FUMARATEActive2007-10-25
  • BOC CORE SUCCINATE (INTERMEDIATE)Active2007-07-15
  • GABAPENTIN USPActive2005-12-04
  • NIACIN USPActive2005-07-05
  • BUPROPION HYDROCHLORIDE USPActive2005-04-24
  • PROGUANIL HYDROCHLORIDEActive2005-02-06
  • IOPAMIDOL USPActive2005-02-06
  • LEVODOPA USPActive2004-12-03
  • CARBIDOPA USPActive2004-11-20
  • PHENYLEPHRINE HYDROCHLORIDE USPActive2003-10-19
  • LEVETIRACETAMActive2003-10-05
  • SULPHAZINEActive2003-09-03
  • NABUMETONE USPActive2001-04-02
  • DILTIAZEM HYDROCHLORIDE USPActive2001-01-26
  • B WINGSActive2000-03-14
  • A WINGSActive2000-03-14
  • NAPROXEN SODIUM USPActive1998-11-27
  • NAPROXEN USPActive1998-11-27
  • DEXTROMETHORPHAN HYDROBROMIDE USPActive1997-02-04
  • VALACYCLOVIR HYDROCHLORIDE USP (HYDROUS FORM)Inactive2014-12-20
  • IRBESARTAN USPInactive2012-09-11
  • TELMISARTAN, USPInactive2012-05-05
  • VIGABATRINInactive2008-04-29
  • TOPIRAMATEInactive2007-11-25
  • TRIPEPTIDE, DRUG INTERMEDIATEInactive2007-10-15
  • TPE ALCOHOLInactive2007-01-07
  • SIBUTRAMINE HYDROCHLORIDE MONOHYDRATEInactive2006-09-04
  • DESLORATADINEInactive2006-05-17
  • TAMSULOSIN HYDROCHLORIDEInactive2005-11-25
  • ZOLPIDEM TARTRATE USPInactive2005-09-25
  • FOSPHENYTOIN SODIUM USPInactive2005-09-25

Showing the 50 most relevant of 56 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to Divis Laboratories, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Divis Laboratories in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Divis Laboratories?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.